Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.89 |
| ▸ | NPC1 | O15118 | 9/20 | 0.89 |
| ▸ | MEN1 | O00255 | 5/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.81 |
| ▸ | PKM | P14618 | 4/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.71 |
| ▸ | F2 | P00734 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.61 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.61 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.61 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366822 | 1.00 | RAB9A (0.89) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL7189774 | 0.98 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2APKM | |
| Hydrochloric Acid SCHEMBL27681799 | 0.98 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2APKM | |
| Benzoic Acid SCHEMBL8529424 | 0.95 | RAB9A (0.80) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL22636483 | 0.95 | RAB9A (0.80) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL7181924 | 0.93 | RAB9A (0.77) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL7179355 | 0.93 | RAB9A (0.77) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL16583895 | 0.91 | RAB9A (0.86) | RAB9ANPC1MEN1KMT2APKM | |
| Acrylic Acid SCHEMBL19137964 | 0.90 | RAB9A (0.73) | RAB9ANPC1MEN1KMT2APKM | |
| SCHEMBL6940180 | 0.90 | RAB9A (1.00) | RAB9ANPC1MEN1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4531856-B1 | BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION | ALK ABELLO AS (DK) | 2026-04-22 | — | — | EP | claimed |
| US-20250295655-A1 | BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION | Alk-Abelló A/S (DK) | 2025-09-25 | — | — | US | claimed |
| EP-3653626-B1 | NOVEL 1H-PYRAZOLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2025-09-17 | — | — | EP | claimed |
| EP-4580404-A2 | SULFONAMIDE APYRASE INHIBITORS | Texas Crop Science, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| EP-4531856-A1 | BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION | ALK-Abelló A/S (DK) | 2025-04-09 | — | — | EP | claimed |
| CN-117777474-A | Sustained-release polycarboxylate water reducer modified graphene oxide, and preparation method and application thereof | 北京建筑材料科学研究总院有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240099300-A1 | SULFONAMIDE APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | claimed |
| CN-117658515-A | Branched-structure graphene oxide-polycarboxylate water reducer composite material and preparation method thereof | 北京工业大学 | 2024-03-08 | — | — | CN | claimed |
| WO-2024050041-A2 | SULFONAMIDE APYRASE INHIBITORS | TEXAS CROP SCIENCE (US) | 2024-03-07 | — | — | WO | claimed |
| US-20240024314-A1 | Methods of Treating Splenomegaly | TELIOS PHARMA, INC. (US) | 2024-01-25 | — | — | US | claimed |
| CN-1626518-A | Method for synthesizing ramification in benzamide class of pyridyl | DALIAN INST OF CHEMICAL PHYUSI (CN) | 2005-06-15 | — | — | CN | claimed |
| CN-1579628-A | Olefine oligomerization catalyst, and its preparation method and use | CHINA PETROCHEMICAL CORP (CN) | 2005-02-16 | — | — | CN | claimed |
| EP-1102743-B1 | AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2002-07-24 | — | — | EP | claimed |
| EP-1140087-A4 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARM CO (US) | 2002-04-03 | — | — | EP | claimed |
| EP-1140087-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Du Pont Pharmaceuticals Company (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000035454-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | claimed |
| EP-0906321-A1 | NOVEL TRANSITION METAL COMPLEXES AND METHOD FOR PREPARING THEM | BOREALIS A/S (DK) | 1999-04-07 | — | — | EP | claimed |
| WO-1997045434-A1 | NOVEL TRANSITION METAL COMPLEXES AND METHOD FOR PREPARING THEM | BOREALIS A/S (DK) | 1997-12-04 | — | — | WO | claimed |
| CN-1098098-A | Piperazine derivatives | WYETH JOHN & BROTHER LTD (GB) | 1995-02-01 | — | — | CN | claimed |
| WO-1993016053-A1 | NOVEL BISTETRAZOL DERIVATIVES HAVING AN ANTIALLERGIC AND CYTOPROTECTIVE ACTIVITY | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1993-08-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240099300-A1 | SULFONAMIDE APYRASE INHIBITORS | APEH, ARSA, DNPEP | RAB9A 1777/4885NPC1 3337/4885MEN1 4795/4885 |
| US-20250295655-A1 | BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION | BTK, SYK, ABL1 | RAB9A 2807/4885NPC1 3643/4885MEN1 3540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.